New biomarker for immunoglobulin A nephropathy identified

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing ...
Yahoo

Renalys eyes Japanese Filspari approval on Phase III IgA nephropathy win

Renalys Pharma is vying for the approval of its in-licensed immunoglobulin A (IgA) nephropathy asset, Filspari (sparsentan) in Japan, following the positive results of a Phase III trial. During the ...
KHON2

Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan

TOKYO, Oct. 10, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") announced today that it has completed data collection for the primary endpoint in the Phase III ...
Morningstar

46th Honda Prize Award Ceremony Held in Honor of Recipient, Dr. Kenichi Iga of Japan

- For Pioneering Contributions to Conception and Development of Vertical-Cavity Surface-Emitting Laser (VCSEL) and Leadership in Its Practical Application - At the opening of the ceremony, Hiroto ...
Optics

Honda Prize 2025 awarded to VCSEL pioneer Kenichi Iga of Japan…

The Honda Foundation has selected Dr. Kenichi Iga, an honorary professor at the Institute of Science Tokyo and the 18th president of former Tokyo Institute of Technology, as the winner of the 2025 ...